Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT(1A) ligands

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 10, 1997, Pages 1036-1041

  Dukić, Sladjana ^a   Kostić Rajačić, Sladjana ^b   Dragović, Deana ^b   Šoškić, Vukic ^a,b   Joksimović, Jelena ^a,c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Institute for Biological Research

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANXIOLYTIC AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; NEUROLEPTIC AGENT; PHENYLPIPERAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SPIPERONE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HIPPOCAMPUS; RADIOASSAY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; SYNAPTIC MEMBRANE;

EID: 0030709249     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06037.x     Document Type: Article

References (17)

1. Ben-Jonathans, N. (1985) Dopamine: a prolactin inhibiting hormone. Endocrinol. Rev. 6: 564-570
2. Broekkamp, C. L. E., Leysen, D., Peeters, B. W. M., Pinder, R. M. (1995) Prospects for improved antidepressants. J. Med. Chem. 38: 4615-4634
3. 1A receptor ligands - 4-(2-heteroarylethyl)-1-arylpiperazines. Arzneim. Forsch. 47: In press
4. 1A serotonin agonists and antagonists. Drug. Dev. Res. 26: 251-274
5. 3H-PAT. Nature 305: 140-142
6. Howard, H. R., Seeger, T. F. (1993) In: Bristol, J. A., (ed.) Novel Antipsychotics. Annu. Rep. Med. Chem. 28: 39-47, Academic Press, San Diego
7. Howard, H. R., Prakasn, S., Seeger, T. F. (1994) Ziprasidone hydrochloride. Drugs Future 19: 560-563
8. 2 ratio hypothesis. Curr. Med. Chem. 1: 50-60
9. Lowe III. J. A., Seeger, T. F., Vinick, F. J. (1988) Atypical anti-psychotics - recent findings and new perspectives. Med. Res. Rev. 8: 475-497
10. Lowe III, J. A., Seeger, T. F., Nagel, A. A., Howard, H. R., Seymour, P. A., Heym, J. H., Ewing, F. E., Newman, M. E., Schmidt, A. W., Furman, J. S., Vincent, L. A., Maloney, P. R., Robinson, G. L., Reynold, L. S., Vinick, F. J. (1991) 1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents. J. Med. Chem. 34: 1860-1866
11. Markwell, M. A. K., Haas, S. M., Bieber, L. L., Tolbert, N. E. (1978) Modification of Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210
12. Munson, P. J., Rodbard, D. (1980) LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107: 220-239
13. Reynolds, G. P. (1992) Developments in the drug treatment of schizophrenia. Trends Pharmacol. Sci. 13: 116-121
14. 2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of hoperidone (HP 873). J. Med. Chem. 38: 1119-1131
15. Tuce, Z., Soskic, V., Joksimovic, J. (1994). Synthesis and binding properties of several new dopaminergic ligands. Drug Design Discovery 11: 251-258
16. 1A receptor ligands. 1. Heterocyclic phenylpiperazines with N4-alkyl substituents. J. Med. Chem. 36: 2751-2760
17. West, S. A., Nemeroff, C. B. (1993) Atypical antipsychotic drugs: current status and future directions. Drugs Today 29: 183-188